OUR TEAM

Lance Alstodt has been appointed the Company’s President, Chief Executive Officer and Chairman of the Board as of Nov 16, 2020. Mr. Alstodt brings over 25 years of experience in leading medical technology and lifesciences companies in operations, capital raising activities, strategy, and mergers and acquisitions.

Most recently, Mr. Alstodt was the Founder and CEO of MedVest Consulting Corporation (“MedVest”), an advisory and capital firm focused exclusively within the healthcare sector, focusing on growth and channel strategy, strategic planning, merger and acquisition support and investor activities.

Prior to MedVest, Mr. Alstodt was a career investment banker with over 25 years of experience in healthcare investment banking, including mergers and acquisitions. In 2011, Mr. Alstodt joined Leerink Partners as Managing Director to help lead its medical technology sector. Mr. Alstodt brings significant domain experience within the orthopedic and spine specific sectors. From 2008-2011, Mr. Alstodt was a Managing Director and Head of Medical Technology at Oppenheimer & Co. From 2000-2008, he was a Managing Director in the Healthcare Group and Global M&A Group at Bank of America Merrill Lynch (“BAML”). Prior to BAML, Mr. Alstodt spent seven years in the Global M&A Group at J.P. Morgan Chase, where he worked extensively on acquisitions, leveraged buyouts, private and public financings, exclusive sales and general advisory assignments.

Mr. Alstodt received a B.A. in Economics from the State University of New York at Albany, with a secondary concentration in Finance and Marketing.

Jatinder Dhaliwal is a registered pharmacist who has served as chief executive officer and director of multiple publicly traded companies listed on Canadian and U.S. exchanges, including the CSE, TSX and Nasdaq.

Mr. Dhaliwal has held chief executive officer and board roles at Akanda Corp., Binovi Technologies Corp., Global Health Clinics Ltd., Virpax Pharmaceuticals, Kiaro Holdings Corp. and EGF Theramed Health Corp. He has also served as a director of Makara Mining, LQR House Inc. and Intact Gold Corp.

Mr. Dhaliwal holds a Bachelor of Pharmacy from the University of British Columbia and a Bachelor of Science in Biology from the University of Victoria.

Mika Grasso is an Investment Director at a family office, where he oversees the firm’s direct investment and co-investment activities, including portfolio construction and capital deployment across private markets.

Mr. Grasso has held investment banking, capital markets and finance roles at Zions Capital Markets, Paulson Investment Company, Goldman Sachs and Power Systems Management. He previously served as a director of Nuwellis, Inc. (Nasdaq: NUWE).

Mr. Grasso received his M.S. in Finance with a concentration in Investment Management and his B.S. in Business Administration, both from the University of Colorado Boulder, Leeds School of Business.

Mr. Rosa serves on the board of directors of NeuroOne and is an entrepreneur with three decades of experience in the medical device industry spanning a variety of technologies and products. In addition to CEO roles with early stage medical device companies, Mr. Rosa’s background also includes senior roles with C.R. Bard Inc., Boston Scientific Inc., and St. Jude Medical, where his responsibilities included marketing, product development and business development. He has been named as an inventor on multiple medical device patents, serves on seven corporate boards, and has raised $200M in the capital markets. Mr. Rosa holds an MBA from Duquesne University, and a BS in Commerce and Engineering from Drexel University.